KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) FCF Margin (2017 - 2025)

Historic FCF Margin for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 80.09%.

  • Bionano Genomics' FCF Margin rose 1390600.0% to 80.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.13%, marking a year-over-year increase of 2140000.0%. This contributed to the annual value of 224.28% for FY2024, which is 1270100.0% up from last year.
  • According to the latest figures from Q3 2025, Bionano Genomics' FCF Margin is 80.09%, which was up 1390600.0% from 51.98% recorded in Q2 2025.
  • Bionano Genomics' 5-year FCF Margin high stood at 43.36% for Q1 2025, and its period low was 585.08% during Q1 2022.
  • For the 5-year period, Bionano Genomics' FCF Margin averaged around 314.21%, with its median value being 322.07% (2021).
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 2885900bps in 2021, then tumbled by -1461900bps in 2022.
  • Bionano Genomics' FCF Margin (Quarter) stood at 416.69% in 2021, then dropped by -5bps to 439.05% in 2022, then soared by 35bps to 284.71% in 2023, then soared by 72bps to 79.68% in 2024, then fell by -1bps to 80.09% in 2025.
  • Its last three reported values are 80.09% in Q3 2025, 51.98% for Q2 2025, and 43.36% during Q1 2025.